Don’t Let These Five Speculative Stock Plays Slip Below The Radar: FPMI,...
By VFC’s Stock House On numerous occasions during the record-breaking rally of 2013 we’ve pointed out the fact that the more speculative and ‘under the radar’ sectors of the investing world are often...
View ArticleSpecialty Pharmacies Offer Solutions — Also For Investors: PMC, BIOS, APHY
By Dutch Trader In 2012, Americans filled more than 4 billion prescriptions at 62,000 retail, mail, and specialty pharmacies. The largest U.S. pharmacies ranked by total prescription you will find in...
View ArticleSirius XM Radio Inc. (NASDAQ:SIRI): Maxim Group Senior Media Analyst John...
By Demian Russian With a new research report, Maxim Group Senior Media Analyst John Tinker weighs in ahead of Sirius XM Radio’s (NASDAQ:SIRI) Q1 earnings release on Tuesday, April 30th. Noting Sirius...
View ArticleStevia First Corp. (STVF): Upside Potential in the Growing All-Natural Sugar...
By Phil Lassiter Stevia First Corp. (STVF) is a small $25 million company that operates in an enormous $100 billion sweetener market. Its targeted market is in stevia, the all-natural sweetener, a...
View ArticleSANUWAVE Health (SNWV): Price Consolidation Positions Company For...
By VFC’s Stock House Shares of SANUWAVE Health, Inc. (SNWV) swiftly achieved a near double in price earlier this year as investor anticipation grew in regards to the initiation of a new Phase III trial...
View ArticleBiotech Rally Creates Fertile M&A Ground for Small Caps: OncoSec Medical Inc....
By AlphaVN While I am not personally a huge fan of high risk, high cost-of-capital businesses, I tend to spend a lot of time writing about them. Mining and high-tech are two of the highest...
View ArticlePharmacy Alliances and the Need for Niche Providers: APHY, WAG, ABC, BIOS,...
By AlphaVN With the upcoming overhaul of the U.S. health care market, known as the Affordable Care Act – that’s ObamaCare in common political parlance – it is expected that there will be a drive...
View ArticleOncoSec Medical (ONCS): A Bright Prospect in a Space That’s About to Get...
By Amy Baldwin Last month, I published an article singling out OncoSec Medical Inc. (OTCMKTS:ONCS) as a dark horse in the bright immunotherapy space. With the immunotherapy forecast poised to get a...
View ArticleArianne Resources (DRRSF) Further Advances Phosphate Deposit Project
By Mobile Guru In a previous article back in January on Arianne Resources Inc. (OTCMKTS:DRRSF), Arianne Resources On Big Fertilizer Stocks Radar, I discussed how Arianne was a potential takeover...
View ArticleArena Pharmaceuticals, Inc. (NASDAQ:ARNA): Belviq Pre-Launch Analysis
By Spencer Osborne The long anticipated launch of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) anti-obesity drug is upon us. On Friday, June 7th, Arena and marketing partner Eisai Co., Ltd. (ESALY) will...
View ArticleCan Stevia Help Soft Drinks Get Past the Obesity and Diabetes Epidemic?...
By Craig Keolanui The worldwide addiction to sugary sweet carbonated beverages has taken its toll on an adoring public, and health experts are starting to raise red flags. Obesity and type-II diabetes...
View ArticleArena Pharmaceuticals, Inc. (NASDAQ:ARNA) and VIVUS, Inc. (NASDAQ:VVUS): Web...
By Spencer Osborne Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and VIVUS, Inc. (NASDAQ:VVUS) both make an anti-obesity product that is on the market. Vivus launched its drug Qsymia last Fall, while Arena...
View ArticleArena Pharmaceuticals (NASDAQ:ARNA) To Make First Post-Launch Presentation
By Spencer Osborne Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and marketing partner Eisai Co., Ltd. (ESALY) launched the anti-obesity drug, Belviq, on June 7th, 2013. Investors are eagerly awaiting some...
View ArticleCan Avastin’s Shortcomings Open the Door for Del Mar Pharmaceuticals Inc....
By Craig Keolanui The effectiveness of Genentech and Roche’s (Roche Holding Ltd., OTCMKTS:RHHBY) glioblastoma multiforme (GBM) treatment, Avastin, has recently been challenged raising concerns from...
View ArticleInteresting Immunotherapy Cancer Stocks: AMGN, ONCS, VICL
By Stone Fox Capital Advisors As with any treatments dealing with cancer, opportunity exists to drastically improve the survival rates and, as importantly, reduce the side effects caused by surgery and...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS): Web...
By Spencer Osborne We are now entering a phase where Arena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS) are going head to head with the goal of trimming pounds off of the citizens of...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS):...
By Spencer Osborne The head to head battle for obesity pill supremacy is just heating up. Weekly script numbers are telling just part of the story. While the battle at the pharmacy gets the most...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS): Weekly...
By Spencer Osborne Once again it is time to look at the weekly web trends for Arena Pharmaceuticals’ (NASDAQ:ARNA) Belviq and Vivus’ (NASDAQ:VVUS) Qsymia. I post this data weekly as a reference for...
View ArticleWhen Does A Reverse Stock Split Make Sense? (MARA, NOG, VHC, VRNG, AIG, CDE)
By Mobile Guru In the investing community, few things can get an investor’s attention faster than hearing the word “Reverse Split”. This is typically because reverse splits are more often than not...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS):...
By Spencer Osborne Once again it is time to look at the weekly web trends for Arena’s (ARNA) Belviq and Vivus’ (VVUS) Qsymia. I post this data weekly as a reference for investors. This week I will add...
View ArticleNeoStem Inc. (NYSEMKT:NBS): On the Leading Edge of the Advancement of Cell...
By Craig Keolanui Is stem cell therapy going to be to the biotechnology industry what Tesla Motors is to the automotive industry? Stem cell therapy has waited at the sidelines while investors pump...
View ArticleCoca-Cola is Now Ready for Change (KO, PEP, STVF, SANW, INGR, SODA, REED,...
By Henry Kawabe The Coca-Cola Company (NYSE:KO) quarterly earnings were very disappointing to most. Immediately after the company’s second quarter report, the stock traded lower by more than 3%; this...
View ArticleStevia First Corporation (STVF): Stevia Extract’s Hidden Health Benefits...
By George Budwell Stevia is a natural sweetener extracted from the leaves of the South and Central American plant Stevia rebaudiana Bertoni, and has been used as a sugar substitute in Brazil and Japan...
View ArticleSirius XM Radio (NASDAQ:SIRI): Wunderlich Securities Media Analyst Matthew...
By Demian Russian Wunderlich Securities Media Analyst Matthew Harrigan will be weighing in on Sirius XM Radio (NASDAQ:SIRI) during an exclusive, live interview on tonight’s Playground Radio program...
View ArticleOncoSec Medical Inc. (OTCMKTS:ONCS): A Presentation Of Catalysts
By Arthur Rhodes The Rodman & Renshaw Investment Conference this week highlighted several of biotechnology’s most exciting companies such as Verastem Inc. (NASDAQ:VSTM), Keryx Biopharmaceuticals...
View Article
